microRNAs and RNA-binding proteins: A complex network of interactions and reciprocal regulations in cancer

RNA Biology

Volumn 10, Issue 6, 2013, Pages 934-942

  Ciafrè, Silvia Anna ^a   Galardi, Silvia ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Cancer; microRNAs; mRNA decay; Post transcriptional regulation; RNA binding proteins

Indexed keywords

HUR PROTEIN; MESSENGER RNA; MICRORNA; RNA BINDING PROTEIN;

3' UNTRANSLATED REGION; BINDING COMPETITION; BINDING SITE; BIOGENESIS; BREAST CANCER; CANCER GENETICS; CANCER GROWTH; CARCINOGENESIS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REGULATORY NETWORK; HUMAN; INTERACTIONS WITH RNA; PROTEIN RNA BINDING; REVIEW;

EID: 84940234906     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.24641     Document Type: Review

References (80)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33; PMID:19167326; http://dx.doi.org/10.1016/j.cell.2009.01.002.
2. Fabian MR, Sonenberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 2012; 19:586-93; PMID:22664986; http://dx.doi.org/10.1038/nsmb.2296.
3. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009; 11:228-34; PMID:19255566; http://dx.doi.org/10.1038/ncb0309-228.
4. Hammell CM. The microRNA-argonaute complex: a platform for mRNA modulation. RNA Biol 2008; 5:123-7; PMID:18698153; http://dx.doi.org/10.4161/ rna.5.3.6570.
5. Keene JD. RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 2007; 8:533-43; PMID:17572691; http://dx.doi.org/10.1038/nrg2111.
6. Dessi E, Quattrone A. Tuning the engine: an introduction to resources on post-transcriptional regulation of gene expression. RNA Biol 2012; 9:1-9.
7. Anders G, Mackowiak SD, Jens M, Maaskola J, Kuntzagk A, Rajewsky N, et al. doRiNA: a database of RNA interactions in post-transcriptional regulation. Nucleic Acids Res 2012; 40(Database issue):D180-6; PMID:22086949; http://dx.doi.org/10.1093/nar/gkr1007.
8. Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH. starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res 2011; 39(Database issue):D202-9; PMID:21037263; http://dx.doi.org/10.1093/nar/gkq1056.
9. Iorio MV, Croce CM. microRNA involvement in human cancer. Carcinogenesis 2012; 33:1126-33; PMID:22491715; http://dx.doi.org/10.1093/carcin/bgs140.
10. Kim MY, Hur J, Jeong S. Emerging roles of RNA and RNA-binding protein network in cancer cells. BMB Rep 2009; 42:125-30; PMID:19335997; http://dx.doi.org/10.5483/BMBRep.2009.42.3.125.
11. Bai Y, Qiu GR, Zhou F, Gong LY, Gao F, Sun KL. Overexpression of DICER1 induced by the upregulation of GATA1 contributes to the proliferation and apoptosis of leukemia cells. Int J Oncol 2013; 42:1317-24; PMID:23426981.
12. Kitagawa N, Ojima H, Shirakihara T, Shimizu H, Kokubu A, Urushidate T, et al. Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma. Cancer Sci 2013; In press; PMID:23398123; http://dx.doi.org/10.1111/cas.12126.
13. Zhu DX, Fan L, Lu RN, Fang C, Shen WY, Zou ZJ, et al. Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia. Cancer Sci 2012; 103:875-81; PMID:22320315; http://dx.doi.org/10.1111/j.1349-7006.2012. 02234.x.
14. Pellegrino L, Jacob J, Roca-Alonso L, Krell J, Castellano L, Frampton AE. Altered expression of the miRNA processing endoribonuclease Dicer has prognostic significance in human cancers. Expert Rev Anticancer Ther 2013; 13:21-7; PMID:23259424; http://dx.doi.org/10.1586/era.12.150.
15. Galgano A, Forrer M, Jaskiewicz L, Kanitz A, Zavolan M, Gerber AP. Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory system. PLoS One 2008; 3:e3164; PMID:18776931; http://dx.doi.org/10.1371/journal.pone.0003164.
16. Kedde M, van Kouwenhove M, Zwart W, Oude Vrielink JA, Elkon R, Agami R. A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility. Nat Cell Biol 2010; 12:1014-20; PMID:20818387; http://dx.doi.org/10.1038/ncb2105.
17. Miles WO, Tschöp K, Herr A, Ji JY, Dyson NJ. Pumilio facilitates miRNA regulation of the E2F3 oncogene. Genes Dev 2012; 26:356-68; PMID:22345517; http://dx.doi.org/10.1101/gad.182568.111.
18. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafrè SA, et al. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 2007; 282:23716-24; PMID:17569667; http://dx.doi.org/10.1074/jbc.M701805200.
19. le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A, et al. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 2007; 26:3699-708; PMID:17627278; http://dx.doi.org/10.1038/sj.emboj.7601790.
20. Nairismägi ML, Vislovukh A, Meng Q, Kratassiouk G, Beldiman C, Petretich M, et al. Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression. Oncogene 2012; 31:4960-6; PMID:22266852; http://dx.doi.org/10.1038/onc.2011.650.
21. Kedde M, Strasser MJ, Boldajipour B, Oude Vrielink JA, Slanchev K, le Sage C, et al. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 2007; 131:1273-86; PMID:18155131; http://dx.doi.org/10.1016/j.cell.2007. 11.034.
22. Bhandari A, Gordon W, Dizon D, Hopkin AS, Gordon E, Yu Z, et al. The Grainyhead transcription factor Grhl3/Get1 suppresses miR-21 expression and tumorigenesis in skin: modulation of the miR-21 target MSH2 by RNA-binding protein DND1. Oncogene 2013; 32:1497-507; PMID:22614019; http://dx.doi.org/10. 1038/onc.2012.168.
23. Léveillé N, Elkon R, Davalos V, Manoharan V, Hollingworth D, Oude Vrielink J, et al. Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. Nat Commun 2011; 2:513; PMID:22027593; http://dx.doi.org/10.1038/ncomms1519.
24. Goswami S, Tarapore RS, Teslaa JJ, Grinblat Y, Setaluri V, Spiegelman VS. MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein. J Biol Chem 2010; 285:20532-40; PMID:20439467; http://dx.doi.org/10.1074/jbc.M110. 109298.
25. Elcheva I, Goswami S, Noubissi FK, Spiegelman VS. CRD-BP protects the coding region of betaTrCP1 mRNA from miR-183-mediated degradation. Mol Cell 2009; 35:240-6; PMID:19647520; http://dx.doi.org/10.1016/j.molcel.2009.06.007.
26. Eiring AM, Harb JG, Neviani P, Garton C, Oaks JJ, Spizzo R, et al. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 2010; 140:652-65; PMID:20211135; http://dx.doi.org/10.1016/j.cell.2010.01.007.
27. Morgan M, Iaconcig A, Muro AF. CPEB2, CPEB3 and CPEB4 are coordinately regulated by miRNAs recognizing conserved binding sites in paralog positions of their 3′-UTRs. Nucleic Acids Res 2010; 38:7698-710; PMID:20660482; http://dx.doi.org/10.1093/nar/gkq635.
28. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435:828-33; PMID:15944707; http://dx.doi.org/10.1038/nature03552.
29. Olive V, Jiang I, He L. mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 2010; 42:1348-54; PMID:20227518; http://dx.doi.org/10.1016/j.biocel.2010.03.004.
30. Lu J, He ML, Wang L, Chen Y, Liu X, Dong Q, et al. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res 2011; 71:225-33; PMID:21199804; http://dx.doi.org/10.1158/0008-5472. CAN-10-1850.
31. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009; 23:1327-37; PMID:19487573; http://dx.doi.org/10.1101/gad.1777409.
32. Tian Q, Liang L, Ding J, Zha R, Shi H, Wang Q, et al. MicroRNA-550a acts as a pro-metastatic gene and directly targets cytoplasmic polyadenylation element-binding protein 4 in hepatocellular carcinoma. PLoS One 2012; 7:e48958; PMID:23145039; http://dx.doi.org/10.1371/journal.pone.0048958.
33. Ortiz-Zapater E, Pineda D, Martínez-Bosch N, Fernández- Miranda G, Iglesias M, Alameda F, et al. Key contribution of CPEB4-mediated translational control to cancer progression. Nat Med 2012; 18:83-90; PMID:22138752; http://dx.doi.org/10.1038/nm.2540.
34. Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS, Chang KW. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol 2010; 46:204-8; PMID:20138800; http://dx.doi.org/10.1016/ j.oraloncology.2009.12.005.
35. Liu X, Wang A, Heidbreder CE, Jiang L, Yu J, Kolokythas A, et al. MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma. FEBS Lett 2010; 584:4115-20; PMID:20816961; http://dx.doi.org/10. 1016/j.febslet.2010.08.040.
36. Glazer RI, Vo DT, Penalva LO. Musashi1: an RBP with versatile functions in normal and cancer stem cells. Front Biosci 2012; 17:54-64; PMID:22201732; http://dx.doi.org/10.2741/3915.
37. Vo DT, Qiao M, Smith AD, Burns SC, Brenner AJ, Penalva LO. The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs. RNA Biol 2011; 8:817-28; PMID:21881409; http://dx.doi.org/10.4161/rna.8.5.16041.
38. Vo DT, Abdelmohsen K, Martindale JL, Qiao M, Tominaga K, Burton TL, et al. The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells. Mol Cancer Res 2012; 10:143-55; PMID:22258704; http://dx.doi.org/10.1158/1541-7786.MCR-11-0208.
39. Cui YH, Xiao L, Rao JN, Zou T, Liu L, Chen Y, et al. miR-503 represses CUG-binding protein 1 translation by recruiting CUGBP1 mRNA to processing bodies. Mol Biol Cell 2012; 23:151-62; PMID:22072795; http://dx.doi.org/10.1091/ mbc.E11-05-0456.
40. Zheng Y, Miskimins WK. CUG-binding protein represses translation of p27Kip1 mRNA through its internal ribosomal entry site. RNA Biol 2011; 8:365-71; PMID:21508681; http://dx.doi.org/10.4161/rna.8.3.14804.
41. Jiang Q, Feng MG, Mo YY. Systematic validation of predicted microRNAs for cyclin D1. BMC Cancer 2009; 9:194; PMID:19538740; http://dx.doi.org/10.1186/ 1471-2407-9-194.
42. Hutvágner G, McLachlan J, Pasquinelli AE, Bálint E, Tuschl T, Zamore PD. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001; 293:834-8; PMID:11452083; http://dx.doi.org/10.1126/science.1062961.
43. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39:673-7; PMID:17401365; http://dx.doi.org/10.1038/ng2003.
44. Ozen M, Creighton CJ, Ozdemir M, Ittmann M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 2008; 27:1788-93; PMID:17891175; http://dx.doi.org/10.1038/sj.onc.1210809.
45. Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S, et al. A MicroRNA targeting dicer for metastasis control. Cell 2010; 141:1195-207; PMID:20603000; http://dx.doi.org/10.1016/j.cell.2010.05.017.
46. Tokumaru S, Suzuki M, Yamada H, Nagino M, Takahashi T. let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 2008; 29:2073-7; PMID:18700235; http://dx.doi.org/10.1093/carcin/bgn187.
47. Chen AJ, Paik JH, Zhang H, Shukla SA, Mortensen R, Hu J, et al. STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA. Genes Dev 2012; 26:1459-72; PMID:22751500; http://dx.doi.org/10.1101/gad. 189001.112.
48. Yang G, Fu H, Zhang J, Lu X, Yu F, Jin L, et al. RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer. Gastroenterology 2010; 138:231-40, e1-5; PMID:19686745; http://dx.doi.org/10.1053/j.gastro.2009.08.001.
49. Bian Y, Wang L, Lu H, Yang G, Zhang Z, Fu H, et al. Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis. Biochem Biophys Res Commun 2012; 422:187-93; PMID:22569043; http://dx.doi.org/ 10.1016/j.bbrc.2012.04.138.
50. Zucconi BE, Wilson GM. Modulation of neoplastic gene regulatory pathways by the RNA-binding factor AUF1. Front Biosci 2011; 16:2307-25; PMID:21622178; http://dx.doi.org/10.2741/3855.
51. Abdelmohsen K, Tominaga-Yamanaka K, Srikantan S, Yoon JH, Kang MJ, Gorospe M. RNA-binding protein AUF1 represses Dicer expression. Nucleic Acids Res 2012; 40:11531-44; PMID:23066106.
52. Danno S, Nishiyama H, Higashitsuji H, Yokoi H, Xue JH, Itoh K, et al. Increased transcript level of RBM3, a member of the glycine-rich RNA-binding protein family, in human cells in response to cold stress. Biochem Biophys Res Commun 1997; 236:804-7; PMID:9245737; http://dx.doi.org/10.1006/bbrc.1997.7059.
53. Sureban SM, Ramalingam S, Natarajan G, May R, Subramaniam D, Bishnupuri KS, et al. Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe. Oncogene 2008; 27:4544-56; PMID:18427544; http://dx.doi.org/10.1038/onc.2008.97.
54. Pilotte J, Dupont-Versteegden EE, Vanderklish PW. Widespread regulation of miRNA biogenesis at the Dicer step by the cold-inducible RNA-binding protein, RBM3. PLoS One 2011; 6:e28446; PMID:22145045; http://dx.doi.org/10.1371/ journal.pone.0028446.
55. Huang Y. A mirror of two faces: Lin28 as a master regulator of both miRNA and mRNA. Wiley Interdiscip Rev RNA 2012; 3:483-94; PMID:22467269; http://dx.doi.org/10.1002/wrna.1112.
56. Michlewski G, Guil S, Cáceres JF. Stimulation of pri-miR-18a processing by hnRNP A1. Adv Exp Med Biol 2010; 700:28-35; http://dx.doi.org/10. 1007/978-1-4419-7823-3-3.
57. Gherzi R, Chen CY, Trabucchi M, Ramos A, Briata P. The role of KSRP in mRNA decay and microRNA precursor maturation. Wiley Interdiscip Rev RNA 2010; 1:230-9; PMID:21935887; http://dx.doi.org/10.1002/wrna.2.
58. Kedde M, Agami R. Interplay between microRNAs and RNA-binding proteins determines developmental processes. Cell Cycle 2008; 7:899-903; PMID:18414021; http://dx.doi.org/10.4161/cc.7.7.5644.
59. Thornton JE, Gregory RI. How does Lin28 let-7 control development and disease? Trends Cell Biol 2012; 22:474-82; PMID:22784697; http://dx.doi.org/10. 1016/j.tcb.2012.06.001.
60. Baou M, Norton JD, Murphy JJ. AU-rich RNA binding proteins in hematopoiesis and leukemogenesis. Blood 2011; 118:5732-40; PMID:21917750; http://dx.doi.org/10.1182/blood-2011-07-347237.
61. Mayr C, Bartel DP. Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009; 138:673-84; PMID:19703394; http://dx.doi.org/10.1016/j.cell.2009.06.016.
62. Matoulkova E, Michalova E, Vojtesek B, Hrstka R. The role of the 3′ untranslated region in post-transcriptional regulation of protein expression in mammalian cells. RNA Biol 2012; 9:563-76; PMID:22614827; http://dx.doi.org/10. 4161/rna.20231.
63. Jain RG, Andrews LG, McGowan KM, Gao F, Keene JD, Pekala PP. Hel-N1, an RNA-binding protein, is a ligand for an A + U rich region of the GLUT1 3′ UTR. Nucleic Acids Symp Ser 1995; 33:209-11; PMID:8643372.
64. Jain RG, Andrews LG, McGowan KM, Pekala PH, Keene JD. Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes. Mol Cell Biol 1997; 17:954-62; PMID:9001249.
65. Fan XC, Steitz JA. HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc Natl Acad Sci USA 1998; 95:15293-8; PMID:9860962; http://dx.doi.org/10. 1073/pnas.95.26.15293.
66. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006; 125:1111-24; PMID:16777601; http://dx.doi.org/10.1016/j. cell.2006.04.031.
67. Kundu P, Fabian MR, Sonenberg N, Bhattacharyya SN, Filipowicz W. HuR protein attenuates miRNA-mediated repression by promoting miRISC dissociation from the target RNA. Nucleic Acids Res 2012; 40:5088-100; PMID:22362743; http://dx.doi.org/10.1093/nar/gks148.
68. Young LE, Moore AE, Sokol L, Meisner-Kober N, Dixon DA. The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2. Mol Cancer Res 2012; 10:167-80; PMID:22049153; http://dx.doi.org/10.1158/1541-7786.MCR-11-0337.
69. Epis MR, Barker A, Giles KM, Beveridge DJ, Leedman PJ. The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells. J Biol Chem 2011; 286:41442-54; PMID:21971048; http://dx.doi.org/10.1074/jbc.M111.301481.
70. Srikantan S, Abdelmohsen K, Lee EK, Tominaga K, Subaran SS, Kuwano Y, et al. Translational control of TOP2A influences doxorubicin efficacy. Mol Cell Biol 2011; 31:3790-801; PMID:21768308; http://dx.doi.org/10.1128/MCB.05639-11.
71. Nitiss JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer 2009; 9:338-50; PMID:19377506; http://dx.doi.org/10.1038/nrc2607.
72. Glorian V, Maillot G, Polès S, Iacovoni JS, Favre G, Vagner S. HuR-dependent loading of miRNA RISC to the mRNA encoding the Ras-related small GTPase RhoB controls its translation during UV-induced apoptosis. Cell Death Differ 2011; 18:1692-701; PMID:21527938; http://dx.doi.org/10.1038/cdd.2011.35.
73. Mukherjee N, Corcoran DL, Nusbaum JD, Reid DW, Georgiev S, Hafner M, et al. Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability. Mol Cell 2011; 43:327-39; PMID:21723170; http://dx.doi.org/10.1016/j.molcel.2011.06.007.
74. Lebedeva S, Jens M, Theil K, Schwanhäusser B, Selbach M, Landthaler M, et al. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol Cell 2011; 43:340-52; PMID:21723171; http://dx.doi.org/10.1016/j.molcel.2011.06.008.
75. Höck J, Weinmann L, Ender C, Rüdel S, Kremmer E, Raabe M, et al. Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. EMBO Rep 2007; 8:1052-60; PMID:17932509; http://dx.doi.org/10.1038/sj.embor.7401088.
76. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, et al. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 2005; 120:623-34; PMID:15766526; http://dx.doi.org/10.1016/j.cell.2004.12.038.
77. Abdelmohsen K, Srikantan S, Kuwano Y, Gorospe M. miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc Natl Acad Sci USA 2008; 105:20297-302; PMID:19088191; http://dx.doi.org/10.1073/pnas.0809376106.
78. Abdelmohsen K, Kim MM, Srikantan S, Mercken EM, Brennan SE, Wilson GM, et al. miR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle 2010; 9:1354-9; PMID:20305372; http://dx.doi.org/10.4161/cc.9.7.11164.
79. Guo X, Wu Y, Hartley RS. MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol 2009; 6:575-83; PMID:19875930; http://dx.doi.org/10.4161/rna.6.5.10079.
80. Xiao L, Cui YH, Rao JN, Zou T, Liu L, Smith A, et al. Regulation of cyclin-dependent kinase 4 translation through CUG-binding protein 1 and microRNA-222 by polyamines. Mol Biol Cell 2011; 22:3055-69; PMID:21737690; http://dx.doi.org/10.1091/mbc.E11-01-0069.